Visalytics
Visalytics
approved EB-2 (NIW)

Postdoctoral Fellow

Biomedical Science · China · 2022-07-19

Processing Time
162 days
Decision Date
2022-07-19
Location
Pennsylvania
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue her research in molecular and cellular cancer biology, cancer chemotherapy, and inflammation. Her work focuses on fundamentally transforming cancer biology research and developing improved treatments for cancer to address the national and global health burden of the disease.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research addresses the tremendous national and global health burden of cancer, which is a pressing issue of national importance.

2 Well-positioned to Advance Endeavor Met

The petitioner's record of 15 publications, 359 citations, and 55 journal reviews demonstrates she is well-positioned to advance her research.

3 Waiver of Job Offer and Labor Certification Met

On balance, her history of innovation and leadership in cancer biology makes her an invaluable asset, justifying the waiver.

Why This Petition Was Approved

The petition was approved based on 15 peer-reviewed scientific articles published in high-impact journals and 359 citations. Additionally, she conducted 55 peer-reviewed journal reviews and received funding from major organizations like the NIH and the Leukemia Research Foundation, satisfying the Dhanasar prongs for national importance and being well-positioned.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Grants
Original Contributions
Judging Experience
Reference Letters Dependent

Similar Cases

Others

Biotechnology · India

WeGreened EB-2 (NIW) approved
Maryland 380 days 2025-04-30
The petitioner proposes to continue research in cancer biology, specifically focusing on the development of gene therapy and immunotherapy. This work involves creating novel non-invasive monitoring methods to improve treatment effectiveness while reducing patient discomfort. The endeavor aims to advance precise cancer treatments and improve public health outcomes in the United States.
View Case

Research Scientist

Biotechnology · Iran

WeGreened EB-2 (NIW) approved
Maryland 470 days 2025-02-28
The petitioner proposes to continue research in molecular biology focusing on the roles of specific proteins and signaling pathways in cancer development. The work involves studying compounds that disrupt survival signals in cancer cells to design highly effective, targeted therapies. The goal is to improve patient survival rates and enhance the precision of cancer treatments globally.
View Case

Others

Biotechnology · Poland

WeGreened EB-2 (NIW) approved
Massachusetts 290 days 2022-01-10
The petitioner proposes to create novel in vivo models to study cancer development, elucidate protein functions, and uncover the roles of transcriptomic machinery. This work aims to increase the understanding of cell cycle proteins critical for cancer growth to improve cancer treatments and immunotherapies.
View Case

Others

Biotechnology · Taiwan

WeGreened EB-2 (NIW) approved
Maryland 464 days 2022-05-21
The petitioner proposes to continue the full characterization of cellular and genetic mechanisms related to cancers that interact with their surrounding microenvironment. The work focuses on improving treatment strategies, identifying therapeutic targets to slow metastasis, and mitigating the economic costs associated with cancer care.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from China

Case data sourced from publicly available petition decisions and case studies. Decision date: 2022-07-19.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 162 days
Criteria Met 3 / 3
Evidence Types 6

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,816
Success Rate 53.6%
Sustained 2,046
Dismissed 1,674

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in China All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist